Selecta Biosciences to Report Second Quarter 2016 Financial Results on Tuesday, August 9 WATERTOWN, Mass., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies, will...

Communications Sales & Leasing To Announce Second Quarter 2016 Financial Results and Host Conference Call LITTLE ROCK, Ark., July 12, 2016 (GLOBE NEWSWIRE) -- Communications Sales & Leasing, Inc. (“CS&L” or the “Company”) (Nasdaq:CSAL) announced today that it will report its second quarter...